Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Deepak Poduval

1PUBLICATIONS

17CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 09, 2025

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Tejas Jammihal, Renee Maria Saliby, Chris Labaki

Pageof 1

Frequent Collaborators

1 joint publications

Tejas Jammihal

1 joint publications

Renee Maria Saliby

1 joint publications

Chris Labaki

1 joint publications

Juan Gallegos

1 joint publications

Talal El Zarif

1 joint publications

Yasmin Nabil Laimon

1 joint publications

Florian A Büttner

1 joint publications

Matthias Schwab

1 joint publications

Rafael C Casellas

1 joint publications

Kunal Rai

Frequent Collaborators

1 joint publications

Tejas Jammihal

1 joint publications

Renee Maria Saliby

1 joint publications

Chris Labaki

1 joint publications

Juan Gallegos

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos